{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,28]],"date-time":"2024-04-28T00:18:49Z","timestamp":1714263529400},"reference-count":9,"publisher":"Japan Society of Plastic and Reconstructive Surgery","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPRS"],"published-print":{"date-parts":[[2024,4,27]]},"DOI":"10.53045\/jprs.2023-0016","type":"journal-article","created":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T22:47:22Z","timestamp":1697064442000},"page":"94-98","source":"Crossref","is-referenced-by-count":0,"title":["Retrospective Evaluation of an Oral Propranolol Delivery Strategy in 25 Cases of Infantile Hemangioma"],"prefix":"10.53045","volume":"3","author":[{"given":"Shinichi","family":"Ashizawa","sequence":"first","affiliation":[{"name":"Department of Dermatology, Institute of Biomedical and Health Sciences, Hiroshima University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanobu","family":"Kan","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Institute of Biomedical and Health Sciences, Hiroshima University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Takahagi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Institute of Biomedical and Health Sciences, Hiroshima University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikio","family":"Kawai","sequence":"additional","affiliation":[{"name":"Kawai Dermatology Clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayuri","family":"Toda","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Institute of Biomedical and Health Sciences, Hiroshima University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasumasa","family":"Iwasaki","sequence":"additional","affiliation":[{"name":"Iwasaki Dermatology\/Plastic Surgery Clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuhei","family":"Karakawa","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Institute of Biomedical and Health Sciences, Hiroshima University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michihiro","family":"Hide","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Institute of Biomedical and Health Sciences, Hiroshima University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akio","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Institute of Biomedical and Health Sciences, Hiroshima University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"31107","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Hidano A, Purwoko R, Jitsukawa K. Statistical survey of skin changes in Japanese neonates. Pediatr Dermatol. 1986 Feb; 3 (2): 140-4.","DOI":"10.1111\/j.1525-1470.1986.tb00505.x"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Mimura H, Akita S, Fujino A, et al. Japanese clinical practice guidelines for vascular anomalies 2017. J Dermatol. 2020 May; 47 (5): e138-83.","DOI":"10.1111\/1346-8138.15189"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kaneko T, Sasaki S, Baba N, et al. Efficacy and safety of oral propranolol for infantile hemangioma in Japan. Pediatr Int. 2017 Aug; 59 (8): 869-77.","DOI":"10.1111\/ped.13318"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Ozeki M, Nozawa A, Hori T, et al. Propranolol for infantile hemangioma: effect on plasma vascular endothelial growth factor. Pediatr Int. 2016 Nov; 58 (11): 1130-5.","DOI":"10.1111\/ped.12981"},{"key":"5","unstructured":"5. L\u00e9aut\u00e9-Labr\u00e8ze C, Hoeger P, Mazereeuw-Hautier J, et al. A randomized, controlled trial of oral propranolol in infantile hemangioma. N Engl J Med. 2015 Feb; 372 (8): 735-46."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Marqueling AL, Oza V, Frieden IJ, et al. Propranolol and infantile hemangiomas four years later: a systematic review. Pediatr Dermatol. 2013 Mar-Apr; 30 (2): 182-91.","DOI":"10.1111\/pde.12089"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Giachetti A, Garcia-Monaco R, Sojo M, et al. Long-term treatment with oral propranolol reduces relapses of infantile hemangiomas. Pediatr Dermatol. 2014 Jan-Feb; 31 (1): 14-20.","DOI":"10.1111\/pde.12239"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Yu Z, Cai R, Chang L, et al. Clinical and radiological outcomes of infantile hemangioma treated with oral propranolol: a long-term follow-up study. J Dermatol. 2019 May; 46 (5): 376-82.","DOI":"10.1111\/1346-8138.14853"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Wedgeworth E, Glover M, Irvine AD, et al. Propranolol in the treatment of infantile haemangiomas: lessons from the European Propranolol in the Treatment of Complicated Haemangiomas (PITCH) Taskforce survey. Br J Dermatol. 2016 Mar; 174 (3): 594-601.","DOI":"10.1111\/bjd.14233"}],"container-title":["Journal of Plastic and Reconstructive Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jprs\/3\/2\/3_2023-0016\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T05:16:11Z","timestamp":1714194971000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jprs\/3\/2\/3_2023-0016\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,27]]},"references-count":9,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.53045\/jprs.2023-0016","relation":{},"ISSN":["2436-259X"],"issn-type":[{"value":"2436-259X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,27]]},"article-number":"2023-0016"}}